Ralliant (NYSE:RAL) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Ralliant (NYSE:RAL) released its quarterly earnings results on Thursday. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05, FiscalAI reports. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The business had revenue of $567.80 million during the quarter. Ralliant updated its FY 2026 guidance to 2.760-2.900 EPS and its Q3 2026 guidance to 0.720-0.780 EPS.

Here are the key takeaways from Ralliant’s conference call:

• Q2 results exceeded guidance, with revenue up 13% year over year to $568 million, adjusted EBITDA margin expanding 390 basis points to 19.8%, and adjusted EPS rising 58% to $0.68. Both segments delivered double-digit organic growth.
• Management raised full-year 2026 guidance to revenue of $2.25 billion–$2.30 billion, adjusted EBITDA margins of 20%–21%, and adjusted EPS of $2.76–$2.90; Q3 revenue is expected at $570 million–$590 million with EPS of $0.72–$0.78.
• Demand remains strong in defense, electrification, utilities, and Test & Measurement, supported by book-to-bill above 1.1 in both segments and defense backlog exceeding $1 billion. The company is expanding manufacturing capacity, including for priority missile programs and utility sensors.
• The Enterprise Productivity Program generated $3 million of savings in Q2 and remains on track for $10 million–$12 million of in-year 2026 savings and $50 million–$60 million of annualized savings by 2028. Free cash flow was $99 million in Q2, while the company returned $161 million to shareholders in the first half.
• Management noted limited visibility in short-cycle Test & Measurement markets and expects growth to moderate after the current recovery year. Semiconductor results will also face a larger year-over-year headwind in Q3 from lapping a major 2025 customer project, while corporate costs are expected to rise to $20 million–$23 million per quarter in the second half.

Ralliant Stock Down 1.7%

RAL stock traded down $1.14 during trading on Friday, reaching $65.86. 271,113 shares of the company traded hands, compared to its average volume of 1,705,290. The business has a 50 day simple moving average of $67.12 and a 200 day simple moving average of $54.26. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. Ralliant has a 12 month low of $37.27 and a 12 month high of $75.41. The company has a market capitalization of $7.37 billion and a price-to-earnings ratio of -6.01.

Ralliant Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 8th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio (DPR) is presently -1.83%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Phocas Financial Corp. raised its stake in Ralliant by 81.2% in the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock worth $7,999,000 after acquiring an additional 70,403 shares during the last quarter. Teacher Retirement System of Texas increased its holdings in shares of Ralliant by 6.9% in the fourth quarter. Teacher Retirement System of Texas now owns 570,878 shares of the company’s stock valued at $29,063,000 after purchasing an additional 36,800 shares during the period. Alpha Omega Wealth Management LLC raised its stake in shares of Ralliant by 615.8% in the fourth quarter. Alpha Omega Wealth Management LLC now owns 40,291 shares of the company’s stock worth $2,051,000 after purchasing an additional 34,662 shares during the last quarter. Irenic Capital Management LP lifted its holdings in shares of Ralliant by 424.1% during the first quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company’s stock worth $72,376,000 after purchasing an additional 1,408,176 shares during the period. Finally, Rokos Capital Management LLP purchased a new stake in Ralliant in the first quarter valued at approximately $42,022,000.

Analysts Set New Price Targets

RAL has been the subject of a number of recent analyst reports. Barclays lifted their price target on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 13th. Citigroup increased their price target on Ralliant from $70.00 to $81.00 and gave the stock a “buy” rating in a report on Monday, July 13th. BMO Capital Markets started coverage on Ralliant in a research note on Monday, July 20th. They set a “market perform” rating and a $78.00 price target for the company. Evercore began coverage on Ralliant in a report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price objective for the company. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $74.40.

Key Ralliant News

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Q2 earnings and revenue beat estimates: Ralliant reported adjusted EPS of $0.68, above the $0.63 consensus and slightly ahead of $0.67 a year earlier. Revenue reached approximately $568 million, up 13% year over year on both a reported and organic basis. Adjusted net earnings were $76 million, while net earnings were $57 million. Ralliant Reports Second Quarter 2026 Results and Raises Full Year Guidance
• Positive Sentiment: Full-year guidance was raised: Ralliant now expects fiscal 2026 adjusted EPS of $2.76 to $2.90, compared with the $2.65 analyst consensus. Full-year revenue guidance was lifted to roughly $2.25 billion to $2.30 billion, also above the approximately $2.2 billion consensus. Ralliant forecasts 2026 revenue and productivity savings
• Positive Sentiment: Near-term outlook also topped expectations: Third-quarter guidance calls for adjusted EPS of $0.72 to $0.78 and revenue of $570 million to $590 million, above consensus estimates of $0.68 and $556.4 million, respectively.
• Positive Sentiment: Cost savings could support margins: Ralliant’s enterprise productivity program is targeting $50 million to $60 million in annualized run-rate savings by 2028, providing a potential longer-term earnings catalyst.
• Neutral Sentiment: Trading volatility increased: RAL was briefly halted under a limit-up/limit-down pause, indicating unusually rapid price movement following the results rather than a fundamental change in the company’s outlook.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.